Statements (18)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:company
|
| gptkbp:acquiredBy |
gptkb:Bausch_Health_Companies
|
| gptkbp:focusesOn |
oral health
|
| gptkbp:foundedYear |
1996
|
| gptkbp:headquartersLocation |
gptkb:Horsham,_Pennsylvania,_United_States
|
| https://www.w3.org/2000/01/rdf-schema#label |
OraPharma
|
| gptkbp:industry |
pharmaceuticals
|
| gptkbp:market |
gptkb:United_States
|
| gptkbp:parentCompany |
gptkb:Bausch_Health_Companies
|
| gptkbp:previousOwner |
gptkb:Johnson_&_Johnson
gptkb:Valeant_Pharmaceuticals |
| gptkbp:product |
gptkb:Arestin
gptkb:NeutraSal |
| gptkbp:specializesIn |
periodontal disease treatments
|
| gptkbp:website |
https://www.orapharma.com/
|
| gptkbp:bfsParent |
gptkb:Bausch_Health_Companies
gptkb:Valeant_Pharmaceuticals |
| gptkbp:bfsLayer |
6
|